Practical Insights on How to Improve Comprehensive Biomarker Testing in Advanced Non-Small Cell Lung Cancer

Sign-up for the second in a 6-part series, titled, “Proactive Interventions for the Prior Authorization Process”

Explore opportunities to expand multidisciplinary care collaboration and coordination to improve care for patients with non-melanoma skin cancers.

Raise awareness among cancer programs of new treatment options for newly diagnosed patients with multiple myeloma ineligible for transplant.

Sign-up for the first in a 6-part series, titled, “Proactive Interventions for the Prior Authorization Process”

Oncology state society leaders from the Appalachian Community Cancer Alliance share an introduction to the Alliance, their insights into the unique needs of the Appalachian region and beyond, how the Alliance is responding and how you can get involved.

In this series, experts share advice on the optimal management of immune-related adverse events (irAEs). Each session covers a different class of irAE-associated immunotherapies and includes evaluation and discussion of one or more case studies.

This educational initiative will focus on multidisciplinary education surrounding TILs, with an emphasis on the importance of implementing clinical trials in the community setting.

Thought leader, Chetan Bettegowda, shares insights with the multidisciplinary team and addresses questions related to their experiences with MCED in real time.

Multiple studies have shown that integrating remote symptom monitoring into cancer care using patient-reported outcomes (PRO) favorably impacts quality of life, healthcare utilization, and overall survival in patients with cancer. However patient adherence with remote PROs outside of a clinical trial is widely variable. With the integration of technology into cancer care and the rapid adoption of telehealth during the pandemic, Dr. Subbiah will present results from an MD Anderson study which seeks to understand the impact of telehealth on patient health behaviors, specifically their adherence with remote symptom monitoring measured by PRO completion patterns, before and during the pandemic.